Sam Harris speaks with Siddhartha Mukherjee, Pulitzer Prize-winning author of The Emperor of All Maladies, about different facets of cancer, from diagnosis to treatment. They discuss the challenges faced by oncologists, delivering bad news, the professionalization of empathy in medicine, and understanding the experience of cancer patients and treatment decisions.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Conveying both statistics and individual truths is crucial in oncology to provide patients with an accurate understanding of their situation.
Maintaining cognitive empathy while avoiding false empathy is important for oncologists when delivering bad news and managing their own emotions.
Deep dives
The Journey into Oncology
Siddhartha Mukherjee became interested in cancer when studying the Epstein-Barr virus and its link to cancer. He discusses the uncertainty in oncology, emphasizing the importance of conveying both statistics and individual truths to patients. He reflects on the balance between professionalized empathy and maintaining personal honesty. Mukherjee encourages patients to read Stephen Gould's essay on locating themselves on the survival curve to make treatment decisions.
The Emotional Struggle
Mukherjee acknowledges the emotional challenges faced by oncologists when delivering bad news and managing their own reactions. He believes in maintaining cognitive empathy while resisting false empathy, reminding patients that the doctor-patient power dynamic lies in favor of the doctor. Mukherjee highlights the importance of understanding the patient's experience while avoiding personal emotional overwhelm.
Understanding Cancer and Patient Perspective
Mukherjee discusses the nature of cancer as a family of diseases that affects individuals to different extents. He encourages patients to gather information to place themselves on the survival curve and make informed treatment decisions. He advocates for clear communication between patients and doctors, particularly regarding endpoints of treatment and indications for more aggressive or palliative care.